Your account is not claimed yet. You can sign up with ORCID to claim your account.

Weijia Cai

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 8

Top Venues

Science advances

Nature communications

Molecular cancer research : MCR

Cancer research

Thomas Jefferson University

Wuhan University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Thomas Jefferson University Nov 1o 2013

United States

Postdoctoral Fellow :: Pathology

Education History

Wuhan University Sep 1o 1997 - Dec 30o 2010

China

PHD :: Life Science College

Publications

Pathum Kossinna, Weijia Cai, Xuewen Lu, Carrie S Shemanko, Qingrun Zhang
Stabilized COre gene and Pathway Election uncovers pan-cancer shared pathways and a cancer-specific driver. Science advances 8 (51) (2022)
Pathum Kossinna, Weijia Cai, Xuewen Lu, Carrie S Shemanko, Qingrun Zhang
Stabilized COre gene and Pathway Election uncovers pan-cancer shared pathways and a cancer-specific driver. Science advances 8 (51) (2022)
Claudia Capparelli, Timothy J Purwin, McKenna Q Glasheen, Signe Caksa, Manoela Tiago, Nicole A Wilski, Danielle Pomante, Sheera Rosenbaum, Mai Q Nguyen, Weijia Cai, Janusz Franco-Barraza, Richard Zheng, Gaurav Kumar, Inna Chervoneva, Ayako Shimada, Vito W Rebecca, Adam E Snook, Kim Hookim, Xiaowei Xu, Edna Cukierman, Meenhard Herlyn, Andrew E Aplin
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma. Nature communications 13 (1) (2022)
Weijia Cai, Mai Q Nguyen, Nicole A Wilski, Timothy J Purwin, Megane Vernon, Manoela Tiago, Andrew E Aplin
A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma. Cancer research 82 (14) (2022)
Megane Vernon, Nicole A Wilski, Daniel Kotas, Weijia Cai, Danielle Pomante, Manoela Tiago, Emad S Alnemri, Andrew E Aplin
Raptinal Induces Gasdermin E-Dependent Pyroptosis in Naïve and Therapy-Resistant Melanoma. Molecular cancer research : MCR 20 (12) (2022)
Weijia Cai, Liya Su, Haifeng Yang
PBRM1 suppresses tumor growth as a novel p53 acetylation reader. Molecular & cellular oncology 7 (3) (2020)
Weijia Cai, Liya Su, Lili Liao, Zongzhi Z Liu, Lauren E Langbein, Essel Dulaimi, Joseph R Testa, Robert G Uzzo, Zhijiu Zhong, Wei Jiang, Qin Yan, Yang Zhang, Haifeng Yang
PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth. Nature communications 10 (1) (2019)
Dan A Erkes, Weijia Cai, Ileine M Sanchez, Timothy J Purwin, Corey Rogers, Conroy O Field, Adam C Berger, Edward J Hartsough, Ulrich Rodeck, Emad S Alnemri, Andrew E Aplin
Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis. Cancer discovery 10 (2) (2019)

Weijia Cai.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Weijia Cai